Hostname: page-component-cd9895bd7-gbm5v Total loading time: 0 Render date: 2024-12-19T06:55:55.407Z Has data issue: false hasContentIssue false
  • English
  • Français

Three-dimensional speckle tracking echocardiography for early detection of left ventricular dysfunction in children with non-alcoholic fatty liver diseases

Published online by Cambridge University Press:  10 December 2020

Doaa El Amrousy Open the ORCID record for Doaa El Amrousy [Opens in a new window] ,
Esam Elgendy ,
Mohiee El-Deen Awad  and
Osama El Razaky
Doaa El Amrousy*
Affiliation:
Pediatric Department, Faculty of Medicine, Tanta University, Egypt
Esam Elgendy
Affiliation:
Pediatric Department, Faculty of Medicine, Tanta University, Egypt
Mohiee El-Deen Awad
Affiliation:
Pediatric Department, Faculty of Medicine, Tanta University, Egypt
Osama El Razaky
Affiliation:
Pediatric Department, Faculty of Medicine, Tanta University, Egypt
*
Author for correspondence: Prof. D. M. El Amrousy, Assistant Professor of Pediatrics, Faculty of Medicine, Tanta University, El Motasem street No 6. Tanta, Egypt. Tel: +201278155283; Fax: +20403280477. E-mail: [email protected]
Get access Rights & Permissions [Opens in a new window]

Abstract

Objectives:

To detect early left ventricular dysfunction in children with non-alcoholic fatty liver disease using three-dimensional speckle tracking echocardiography.

Methods:

Forty obese children with non-alcoholic fatty liver disease were included as group I. Another 40 obese children without non-alcoholic fatty liver disease of matched age, sex, and weight were included as group II. Forty healthy controls of matched age and sex served as a control group. Anthropometric measurements, laboratory investigations, and echocardiographic examinations including three-dimensional speckle tracking echocardiography were measured for all included children.

Results:

Abnormal lipid profile was detected in children with non-alcoholic fatty liver disease. Troponin I levels were significantly higher in children with non-alcoholic fatty liver disease compared to obese children without non-alcoholic fatty liver disease and to healthy controls. Three-dimensional speckle tracking echocardiography examination revealed a significant reduction of left ventricular global longitudinal strain, circumferential strain, radial strain, and area strain in children with non-alcoholic fatty liver disease inspite of normal left ventricular fraction shortening measured by conventional echocardiography. All strains were negatively correlated with the grade of non-alcoholic fatty liver disease.

Conclusion:

Non-alcoholic fatty liver disease is associated with subclinical left ventricular dysfunction. Three-dimensional speckle tracking echocardiography can be helpful in identifying early left ventricular dysfunction in children with non-alcoholic fatty liver disease even in the presence of normal left ventricular ejection fraction.

Keywords

Non-alcoholic fatty liver disease3D-STEchildrencardiac strain
Type
Original Article
Information
Cardiology in the Young , Volume 31 , Issue 4 , April 2021 , pp. 562 - 567
Check for updates
Copyright
© The Author(s), 2020. Published by Cambridge University Press

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Temple, JL, Cordero, P, Li, J, Nguyen, V, Oben, JA. A guide to non-alcoholic fatty liver disease in childhood and adolescence. Int J Mol Sci 2016; 17: 947.CrossRefGoogle ScholarPubMed
Abd El-Kader, SM, El-Den Ashmawy, EM. Non-alcoholic fatty liver disease: the diagnosis and management. World J Hepatol 2015; 7: 846–858.CrossRefGoogle ScholarPubMed
Adams, LA, Lindor, KD. Nonalcoholic fatty liver disease. Ann Epidemiol 2007; 17: 863–869.CrossRefGoogle ScholarPubMed
Assy, N, Djibre, A, Farah, R, Grosovski, M, Marmor, A. Presence of coronary plaques in patients with nonalcoholic fatty liver disease. Radiology 2010; 254: 393–400.CrossRefGoogle ScholarPubMed
Jaruvongvanich, V, Chenbhanich, J, Sanguankeo, A, Rattanawong, P, Wijarnpreecha, K, Upala, S. Increased arterial stiffness in nonalcoholic fatty liver disease: a systematic review and meta-analysis. Eur J Gastroenterol Hepatol 2017; 29: e28–35.CrossRefGoogle ScholarPubMed
Goland, S, Shimoni, S, Zornitzki, T, et al. Cardiac abnormalities as a new manifestation of nonalcoholic fatty liver disease: echocardiographic and tissue Doppler imaging assessment. J Clin Gastroenterol 2006; 40: 949–955.CrossRefGoogle ScholarPubMed
Fotbolcu, H, Yakar, T, Duman, D, et al. Impairment of the left ventricular systolic and diastolic function in patients with non-alcoholic fatty liver disease. Cardiol J 2010; 17: 457–463.Google ScholarPubMed
Targher, G, Day, CP, Bonora, E. Risk of cardiovascular disease in patients with nonalcoholic fatty liver disease. N Engl J Med 2010; 363: 1341–1350.CrossRefGoogle ScholarPubMed
Bonapace, S, Perseghin, G, Molon, G, et al. Nonalcoholic fatty liver disease is associated with left ventricular diastolic dysfunction in patients with type 2 diabetes. Diabetes Care 2012; 35: 389–395.CrossRefGoogle ScholarPubMed
Karabaya, CY, Kocabaya, G, Kalaycıa, A, et al. Impaired left ventricular mechanics in nonalcoholic fatty liver disease: a speckle-tracking echocardiography study. Eur J Gastroenterol Hepatol 2014; 26: 325–331.CrossRefGoogle Scholar
El Razaky, O, El Amrousy, D, Elrifaey, S, Elgendy, M. Three-dimensional speckle tracking echocardiography: is it the magic wand in the diagnosis of subclinical myocardial dysfunction in children with type 1 diabetes mellitus? Echocardiography 2018; 35: 1657–1663 CrossRefGoogle Scholar
Lee, H, Kim, G, Choi, YJ, et al. Association between non-alcoholic steatohepatitis and left ventricular diastolic dysfunction in type 2 diabetes mellitus. Diabetes Metab J 2019; 43: e11.Google Scholar
Dhingra, R, Gona, P, Wang, TJ, Fox, CS, D’Agostino, RB Sr, Vasan, RS. Serum gamma-glutamyl transferase and risk of heart failure in the community. Arterioscler Thromb Vasc Biol 2010; 30: 1855–1860.CrossRefGoogle Scholar
Wang, Y, Tuomilehto, J, Jousilahti, P, et al. Serum gamma-glutamyl transferase and the risk of heart failure in men and women in Finland. Heart 2013; 99: 163–167.CrossRefGoogle ScholarPubMed
Wannamethee, SG, Whincup, PH, Shaper, AG, Lennon, L, Sattar, N. Gamma-glutamyl transferase, hepatic enzymes, and risk of incident heart failure in older men. Arterioscler Thromb Vasc Biol 2012; 32: 830–835.CrossRefGoogle ScholarPubMed
Amin, S, El Amrousy, D, Elrifaey, S, Gamal, S, Hodeib, H. Serum osteocalcin levels in children with nonalcoholic fatty liver disease. JPGN 2018; 66: 117–121.Google ScholarPubMed
Fargion, S, Porzio, M, Fracanzani, AL. Nonalcoholic fatty liver disease and vascular disease: state-of-the-art. World J Gastroenterol 2014; 20: 13306–13324.CrossRefGoogle ScholarPubMed
Zamirian, M, Samiee, E, Moaref, A, Abtahi, F, Tahamtan, M. Assessment of subclinical myocardial change in non-alcoholic fatty liver disease: a case-control study using speckle tracking echocardiography. IJMS 2018; 43: 466–472.Google Scholar
Elsaidi, S, Mira, MF, Sharaf, S, et al. Left ventricular diastolic dysfunction without left ventricular hypertrophy in obese children and adolescents: a Tissue Doppler Imaging and Cardiac Troponin I Study. Cardiol Young 2017; 28: 1–9.Google Scholar
Jung, JY, Park, SK, Ryoo, JH, et al. The effect of non-alcoholic fatty liver disease on left ventricular diastolic function and geometry in Korean general population. Hepatol Res 2017; 47: 522–532.CrossRefGoogle ScholarPubMed
Sert, A, Pirgon, O, Aypar, E, Yilmaz, H, Odabas, D. Relationship between left ventricular mass and carotid intima media thickness in obese adolescents with non-alcoholic fatty liver disease. J Pediatr Endocrinol Metab 2012; 25: 927–934.CrossRefGoogle ScholarPubMed
Pacifico, L, Di Martino, M, De Merulis, A, et al. Left ventricular dysfunction in obese children and adolescents with nonalcoholic fatty liver disease. Hepatology 2014; 59: 461–470.CrossRefGoogle ScholarPubMed
VanWagner, LB, Wilcox, JE, Colangelo, LA, et al. Association of nonalcoholic fatty liver disease with subclinical myocardial remodeling and dysfunction: a population-based study. Hepatology 2015; 62: 773–783.CrossRefGoogle ScholarPubMed
Degertekin, B, Ozenirler, S, Elbeg, S, Akyol, G. The serum endothelin-1 level in steatosis and NASH, and its relation with severity of liver fibrosis. Dig Dis Sci 2007; 52: 2622–2628.CrossRefGoogle ScholarPubMed
Petta, S, Argano, C, Colomba, D, et al. Epicardial fat, cardiac geometry and cardiac function in patients with non-alcoholic fatty liver disease: association with the severity of liver disease. J Hepatol 2015; 62: 928–933.CrossRefGoogle ScholarPubMed
van Heerebeek, L, Hamdani, N, Handoko, ML, et al. Diastolic stiffness of the failing diabetic heart: importance of fibrosis, advanced glycation end products, and myocyte resting tension. Circulation 2008; 117: 43–51.CrossRefGoogle ScholarPubMed
Ersboll, M, Valeur, N, Mogensen, UM, et al. Prediction of all-cause mortality and heart failure admissions from global left ventricular longitudinal strain in patients with acute myocardial infarction and preserved left ventricular ejection fraction. J Am Coll Cardiol 2013; 61: 2365–2373.CrossRefGoogle ScholarPubMed
Stanton, T, Leano, R, Marwick, TH. Prediction of all-cause mortality from global longitudinal speckle strain: comparison with ejection fraction and wall motion scoring. Circ Cardiovasc Imaging 2009; 2: 356–364.CrossRefGoogle ScholarPubMed
Karabay, CY, Kocabay, G, Kalayci, A, et al. Impaired left ventricular mechanics in nonalcoholic fatty liver disease: a speckle-tracking echocardiography study. Eur J Gastroenterol Hepatol 2014; 26: 325–331.CrossRefGoogle ScholarPubMed
Breaker, SJ. The importance of long axis ventricular function. Heart 2000; 84: 577–578.CrossRefGoogle Scholar
Wang, Q, Ma, W, Xia, J. Nonalcoholic fatty liver is associated with further left ventricular abnormalities in patients with type 2 diabetes mellitus. J Ultrasound Med 2018; 37: 1899–1911.CrossRefGoogle ScholarPubMed
Gastaldelli, A. Fatty liver disease: the hepatic manifestation of metabolic syndrome. Hypertens Res 2010; 33: 546–547.CrossRefGoogle ScholarPubMed
Kotronen, A, Yki-Jarvinen, H. Fatty liver: a novel component of the metabolic syndrome. Arterioscler Thromb Vasc Biol 2008; 28: 27–38.CrossRefGoogle ScholarPubMed
Tadic, M, Cuspidi, C, Majstorovic, A, et al. Does the metabolic syndrome impact left-ventricular mechanics? A two-dimensional speckle tracking study. J Hypertens 2014; 32: 1870–1878.CrossRefGoogle ScholarPubMed